National press release of VeriMed readers on ambuances

1. VeriChip News Release
VeriMed Expands to Emergency
Medical Responders
November 14 2007
VeriMed Patient Identification System
Expands to Emergency Medical
Responders-- 27 American Medical
Response Ambulances Equipped with
VeriMed Wireless Scanners
AMR Relationship establishes VeriMed link from long-term care facilities to
ambulances to hospitals
DELRAY BEACH, FL – November 14, 2007 – VeriChip Corporation
(the “Company”) (NASDAQ: CHIP), a provider of radio
frequency identification (RFID) systems for healthcare
and patient-related needs, announced today that its
VeriMed Patient Identification System has expanded to
Emergency Medical Responders. The Company has
equipped 27 American Medical Response (AMR)
ambulances in three counties in the Atlanta metro area
with Bluetooth®-enabled scanners. These ambulances
are the first fleet of its kind in the country to be equipped
with the VeriMed system for both emergency and non-
emergency transport of residents and patients from more
than 20 senior independent living facilities, assisted living
facilities and nursing homes in Fulton, DeKalb and
Clayton Counties.
The VeriMed Patient Identification System, which consists
of a hand-held RFID scanner, an implantable RFID
microchip, and a secure patient database, is used to help
rapidly identify and provide access to important health
information on participating patients. By outfitting these
ambulances to be VeriMed enabled, long-term care
http://www.verichipcorp.com/news/1195048590 (1 of 3)6/9/2008 5:06:22 AM

2. VeriChip News Release
facilities are better able to attract prospective residents
and patients by offering more efficient solutions for
geriatric care. Residents and patients can now have their
portable electronic medical records available at all times
from their facility to ambulance to hospital.
Scott R. Silverman, Chairman and Chief Executive Officer
of VeriChip, said, “This relationship with AMR, the leading
provider of medical transport in the U.S., is an important
step in the build-out of the VeriMed Patient Identification
System. By equipping ambulances to quickly identify
patients and their health records, medical personnel can
immediately begin to care for these patients. With over
900 hospitals now enrolled in the VeriMed system, this is
a logical extension to comprehensive coverage.”
About VeriChip
VeriChip Corporation, headquartered in Delray Beach,
Florida, develops, markets and sells radio frequency
identification, or RFID, systems used to identify, locate
and protect people and assets. VeriChip's goal is to
become the leading provider of RFID systems for people
in the healthcare industry. The Company recently began
marketing its VeriMed(TM) Patient Identification System
for rapidly and accurately identifying people who arrive in
an emergency room and are unable to communicate. This
system uses the first human-implantable passive RFID
microchip, the implantable VeriChip(TM), cleared for
medical use in October 2004 by the United States Food
and Drug Administration.
VeriChip Corporation is majority-owned by Applied Digital
Solutions, Inc. (NASDAQ: ADSX), which also owns a
majority position in Digital Angel Corporation (AMEX:
DOC). Digital Angel, a leader in RFID and GPS
technologies, owns the patent on the human implantable,
passive RFID microchip and manufactures it for VeriChip.
For more information on VeriChip, please call 1-800-970-
2447, or email info@verichipcorp.com. Additional
information can be found online at www.verichipcorp.com.
Statements about the Company's future expectations, including
future revenues and earnings, and all other statements in this
press release other than historical facts are "forward-looking
statements" within the meaning of Section 27A of the Securities
Act of 1933, Section 21E of the Securities Exchange Act of
1934, and as that term is defined in the Private Litigation
http://www.verichipcorp.com/news/1195048590 (2 of 3)6/9/2008 5:06:22 AM

3. VeriChip News Release
Reform Act of 1995. Such forward-looking statements involve
risks and uncertainties and are subject to change at any time,
and the Company's actual results could differ materially from
expected results. The Company undertakes no obligation to
update forward-looking statements to reflect subsequently
occurring events or circumstances.
###
CONTACTS:
Dan Schustack
CEOcast
212-732-4300
Dschustack@ceocast.com
Allison Tomek
VeriChip Corporation
(561) 805-8008
atomek@adsx.com
http://www.verichipcorp.com/news/1195048590 (3 of 3)6/9/2008 5:06:22 AM